Matters

  • Represented Amedisys, Inc., a leading provider of home health and hospice care, in its $3.3 billion sale to UnitedHealth Group’s Optum, a leading information and technology-enabled health services business.
  • Represented Keystone Perfusion Services, a leading provider of organ recovery and perfusion services, in the sale of all of its issued and outstanding membership interests to Strata Critical Medical, a national provider of critical medical logistics and transplant services, creating the only full-service organ transplant services provider offering surgical recovery, normothermic regional perfusion services, logistics and organ placement.
  • Represented an Idaho-based owner and operator of a large portfolio of skilled nursing facilities across the West and Pacific Northwest in the sale of its portfolio to a New York City-based health care real estate investment firm in a complex, multi-state transaction.
  • Represented BrightSpring Health Services in the sale of its community living business to Sevita, a private equity-backed provider of home and community-based specialty health care, enabling the company to focus on its core service offerings.
  • Represented HCA Healthcare in a series of strategic acquisitions, including a 330-bed acute care hospital in New Hampshire and multiple freestanding emergency centers in Texas. These transactions expanded HCA’s national footprint and enhanced its ability to deliver high-quality, accessible care across key markets.
  • Represented Millennium International, a leading provider of business and regional jet avionics repair solutions, in the sale of 90% of its stock to HEICO Corporation, enabling Millennium to drive innovation and broaden its capabilities while supporting HEICO’s expansion into the business jet market.
  • Represented a New Jersey-based developer of a cloud communications platform in its sale to a California-based communications services company operating a cloud-based platform for home phone services.
  • Represented a Massachusetts-based, private equity-backed drug development company in the sale of a wholly owned subsidiary to a biotechnology company.
  • Represented a Pennsylvania-based manufacturer and supplier of semiconductor capital equipment in the sale of its Taiwan-based operating division to a leading provider of automation solutions to the semiconductor industry.